NEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- In 2021, the systemic scleroderma treatment market was valued at nearly US$ 749.4 Mn, and is estimated to expand at a CAGR of 8% over the forecast period ...

A chronic autoimmune disease of the skin, called scleroderma, is not contagious or infectious and often not harmful. However, when this connective tissue disorder involves any internal organs, it can ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

Please provide your email address to receive an email when new articles are posted on . BLR-200 has yielded “promising” results in ongoing research. The therapy targets multiple drivers of scleroderma ...

Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Systemic Scleroderma Treatment Market, by Drug Class, by Disease Type, by Route of Administration, by Distribution Channel, and by Region - Size, Share, ...

A molecule that was until recently known as a brake on inflammation has now been implicated in fibrosis in scleroderma patients. Scleroderma is an autoimmune disease that causes a buildup of scar ...

DEAR MAYO CLINIC: I’m a 50-year-old woman recently diagnosed with scleroderma. What causes it, and can anything stop its progression? What medications are available, and at what point should I begin ...

A prospective study of eighteen patients with morphea found that ultrasound-measured dermal thickness significantly decreased with treatment, positioning high-frequency ultrasound as a promising ...

Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease ...